Physician profile
April Smith
NPI 1346605557
$3,780.88
in general payments reported to CMS, 2019-2025
25 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what 91% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,123 · 2024: $1,076 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,765 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,764.77 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $865.98 | 2023-2025 | Caplyta |
| Alkermes, INC. | $825.31 | 2023-2025 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $403.88 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Corium, LLC | $317.84 | 2023-2024 | Azstarys |
| Axsome Therapeutics, INC. | $253.94 | 2023-2025 | Auvelity, Sunosi |
| Jazz Pharmaceuticals INC. | $228.13 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $182.86 | 2023-2025 | Austedo Xr, Austedo Xr, Uzedy |
| E.R. Squibb & Sons, L.L.C. | $173.96 | 2025 | Cobenfy |
| Harmony Biosciences LLC | $145.83 | 2024-2025 | |
| Organon LLC | $51.14 | 2023 | Nexplanon |
| Pfizer INC. | $40.90 | 2023 | |
| Janssen Pharmaceuticals, INC | $38.75 | 2023-2024 | Invega Sustenna |
| Nestle Healthcare Nutrition INC. | $32.74 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.25 | 2023-2024 | Xifaxan |
| Abbvie INC. | $23.76 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $20.71 | 2025 | Yorvipath |
| Almatica Pharma LLC | $20.64 | 2025 | Teriparatide, Loreev Xr |
| Biogen, INC. | $20.26 | 2025 | Zurzuvae |
| Sanofi Pasteur INC. | $17.90 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.44 | 2023 | |
| Exact Sciences Corporation | $15.31 | 2024 | Cologuard Collection Kit |
| Avadel Cns Pharmaceuticals, LLC | $15.23 | 2024 | Lumryz |
| Collegium Pharmaceutical, INC. | $14.60 | 2025 | Jornay Pm |
| Novo Nordisk INC | $13.84 | 2024 | |
| Merck Sharp & Dohme LLC | $13.68 | 2024 | Capvaxive, Gardasil 9, Gardasil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.